Navigation Links
Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
Date:4/25/2013

Palo Alto, CA (PRWEB) April 25, 2013

Centrillion Biosciences, a leading genomic and bioinformatics solution provider, has announced a new grant program focused on innovation in the application of next-gen sequencing technology. The Sequencing Innovation Grant award is open to academic, clinical and industrial researchers. The Grant will be awarded to research proposals demonstrating innovative applications of next generation sequencing technology.

Grants will be awarded in the form of sample sequencing and bioinformatics analysis services for moderate sized projects. Projects involving whole genomes, exomes, targeted and transcriptome sequencing are eligible.

While the grant is open to all researchers, the initial focus will be on encouraging investigators who are new to next generation sequencing technology to embark on pilot projects that have the greatest potential to lead to significant research programs. The study areas are open but proposals to further findings that may lead to potential clinical applications of sequencing results are especially encouraged.

“Centrillion is a leader in deploying genomics research services to academic and clinical researchers”, said Wei Zhou, CEO of Centrillion, “With this program, we hope to encourage more researchers to apply advanced genomic technologies to advance their research goals.”

Proposals will be reviewed by a Centrillion-appointed committee consisting of Ph.D. level scientists with significant next generation sequencing and genomics technical application experience.

The program is open to all researchers in the USA. The submission deadline is May 17, 2013. Full details may be found on the Centrillion web site: http://www.centrillionbio.com

About Centrillion Biosciences Inc.
Centrillion Biosciences is a leading genomic and bioinformatics solution provider. Our genomic technology dramatically improves sequencing performance and is compatible with leading genomic technology platforms. With the highest customer return and referral rate, our genomic and bioinformatics services utilize leading technologies and beyond to deliver the highest quality data in the fastest sample to result time. Our world class genomic technology development expertise enables our customers to succeed in the most challenging genomic research projects.

Media Contacts
Robert Feldman, Ph.D.
Vice President of Business Development
Centrillion Biosciences, Inc.
2438 Embarcadero Way
Palo Alto, CA 94303
(650) 318-6235
pr(at)centrillionbio(dot)com

Read the full story at http://www.prweb.com/releases/2013/4/prweb10668083.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
5. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
6. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
9. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
10. Ambit Biosciences to Present at Two Upcoming Investor Conferences
11. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... LOUISVILLE, Ky. , Jan. 16, 2017  Eurofins ... service, which will allow more customers to receive their ... price premium or compromise in quality found with other ... the United States at no additional ... variety of routine genetic studies, including DNA sequencing, genotyping, ...
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global Biopolymers ... ... of 16.83% during the period 2017-2021. The report covers ... for 2017-2021. To calculate the market size, the report considers the revenue ... includes a a discussion of the key vendors operating in this market. ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... A SUCCESS , VTI, Vertebral Technologies, Inc., announces the successful outcome of ... device. Since September 2016, VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based ...
(Date:1/12/2017)... , ... January 12, 2017 , ... ... targeted treatments, 26-year-old Lisa Rosendahl’s doctors gave her only a few months to ... new drug combination that has stabilized Rosendahl’s disease and increased both the quantity ...
Breaking Biology Technology:
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
(Date:1/3/2017)... Jan. 3, 2017 Onitor, provider of digital ... Onitor Track, an innovative biometric data-driven program designed to ... month at the 2017 Consumer Electronics Show (CES) in ... In the U.S., the World Health Organization (WHO), have ... of adults who are overweight or obese. WHO also ...
(Date:12/22/2016)... , December 22, 2016 SuperCom ... of secure solutions for the e-Government, Public Safety, HealthCare, and Finance ... of SuperCom, has been selected to implement and deploy a community-based ... Northern California , further expanding its presence in ... This ...
Breaking Biology News(10 mins):